Therapeutic decision making in autoimmune and inflammatory disorders of the central nervous system in children. [PDF]
, 2016 Autoimmune and inflammatory disorders of the central nervous system can result in significant morbidity and mortality. Through the recognition of syndromes using diagnostic biomarkers, the clinician is now able to use immune suppressive therapies to ...
Dale, Rc, Lim, M., Nosadini, M
core +3 more sources
Criteria for the diagnosis of corticobasal degeneration [PDF]
, 2013 Current criteria for the clinical diagnosis of pathologically confirmed corticobasal degeneration (CBD) no longer reflect the expanding understanding of this disease and its clinicopathologic correlations.
Armstrong, Melissa J +19 more
core +1 more source
Current Opinion in Neurology, 1996 Physiological investigations continue to define the processes underlying different types of myoclonus, particularly cortical forms. Several new aetiologies have been described and genetic advances have revealed the basic deficit in familial hyperekplexia.
openaire +6 more sources
A Rare Neurological Complication of Ranolazine
Case Reports in Neurological Medicine, 2013 Myoclonus is not a known side effect of ranolazine. We report a case of myoclonus in a 72-year-old female who underwent cardiac catheterization for angina and was started on ranolazine after the procedure. Two days after ranolazine therapy on 1000 mg per
Jahan Porhomayon +2 more
doaj +1 more source
Myoclonus-dystonia : distinctive motor and non-motor phenotype from other dystonia syndromes [PDF]
, 2019 Background: myoclonus-dystonia (M-D) due to a pathogenic variant of SGCE is an autosomal dominant inherited movement disorder. Apart from motor symptoms, psychiatric disorders are highly prevalent in patients with MD.
Bartels, Anna L. +8 more
core +2 more sources
Subtyping somatic tinnitus: a cross-sectional UK cohort study of demographic, clinical and audiological characteristics [PDF]
, 2015 Somatic tinnitus is the ability to modulate the psychoacoustic features of tinnitus by somatic manoeuvres. The condition is still not fully understood and further identification of this subtype is essential, particularly for the purpose of establishing ...
Hall, Deborah A +4 more
core +6 more sources
Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus–Dystonia Syndrome
Tremor and Other Hyperkinetic Movements, 2016 Background: Acquired neurogenic stuttering has been considered a fairly uncommon clinical occurrence; speech-activated myoclonus is a rare entity that can mimic stuttering and is caused by a wide array of etiologies.Case Report: Here we report ...
Peter Hedera, David Isaacks
doaj +1 more source
Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report [PDF]
, 2014 Introduction. Chronic post-anoxic myoclonus, also known as Lance-Adams syndrome, may develop following hypoxic brain injury, and is resistant to pharmacological therapy. Case report.
Božić Ksenija +4 more
core +1 more source
Palatal myoclonus secondary to neurosarcoidosis
Clinical Case Reports, 2020 Palatal myoclonus can be primary or secondary. In primary palatal myoclonus, no obvious structural brain lesions can be found within the triangle of Guillain and Mollaret.
Devanshi Dharaiya, Anza B. Memon
doaj +1 more source
Comparison of priming versus slow injection for reducing etomidate-induced myoclonus: a randomized controlled study [PDF]
Korean Journal of Anesthesiology, 2018 Background Etomidate injection is often associated with myoclonus. Etomidate injection technique influences the incidence of myoclonus. This study was designed to clarify which of the two injection techniques—slow injection or priming with etomidate—is ...
Parul Mullick +4 more
doaj +1 more source